Suppr超能文献

甲状腺上皮性胸腺瘤(ITET)和具有胸腺样分化的癌(CASTLE):模拟甲状腺鳞状细胞癌的 CD5 阳性肿瘤。

Intrathyroid epithelial thymoma (ITET) and carcinoma showing thymus-like differentiation (CASTLE): CD5-positive neoplasms mimicking squamous cell carcinoma of the thyroid.

机构信息

Department of Medical Technology, Kobe-Tokiwa University, Kobe 653-0838, Japan.

出版信息

Histol Histopathol. 2013 May;28(5):543-56. doi: 10.14670/HH-28.543. Epub 2012 Dec 11.

Abstract

Carcinoma of possible thymic epithelial origin may occur within the thyroid gland, which was first reported by Miyauchi et al. as intrathyroid epithelial thymoma (ITET). ITET is a rare tumor comprising about 0.08% of all primary thyroid malignancies. It is a low-grade thyroid carcinoma with squamous cell differentiation whose overall survival rate was found to be 71%. Lymph node metastasis at surgery was found in 40% and hematogenous metastases developed in bones, liver and lungs. This tumor grows within the thyroid gland and invades into the thyroid parenchyma as well as into the extrathyroid structures. It is a well-circumscribed solid tumor with a sharp tumor border, but is not capsulated. After fixation, the cut surface of the tumor is gray-white in color and is a solid tumor with lobulation. Tumor calcification was not detected in our 15 cases. The tumor cells show solid sheets of growth with occasional keratinization without follicular or papillary structures. Lymphocytic infiltration in the stroma is one of the most characteristic features of this tumor. The tumor cells are polygonal epithelial cells with distinct nucleoli and ill-defined cell border. Positive immunoreactivity for CD5 is a key feature to differentiate it from undifferentiated carcinoma, poorly differentiated carcinoma, medullary (C cell) carcinoma and high-grade squamous cell carcinoma (so-called primary squamous cell carcinoma) of the thyroid. Negative immunoreactivity for calcitonin, TTF1 and thyroglobulin, and positive immunoreactivity for p63 and KIT are also helpful for differential diagnosis. Nuclear atypia is mild and mitoses are less frequent, with an intermediate proliferation index (MIB-1 labeling index is usually less than 20%), which are also helpful to differentiate it from high-grade primary squamous cell carcinoma of the thyroid. The tumors in our 15 cases demonstrate 3 histological subtypes: keratinizing squamous cell carcinoma type, non-keratinizing basaloid cell carcinoma (lymphoepithelioma-like) type and neuroendocrine carcinoma type, which correspond to subtypes of the mediastinal thymic carcinomas.

摘要

可能来源于胸腺上皮的甲状腺癌可发生于甲状腺内,这首先由 Miyauchi 等人报道为甲状腺内上皮性胸腺瘤(ITET)。ITET 是一种罕见的肿瘤,占所有原发性甲状腺恶性肿瘤的 0.08%左右。它是一种低级别甲状腺癌,具有鳞状细胞分化,总生存率为 71%。手术时发现淋巴结转移占 40%,血行转移至骨骼、肝脏和肺部。这种肿瘤在甲状腺内生长,侵犯甲状腺实质和甲状腺外结构。它是一种界限清楚的实性肿瘤,边界锐利,但无包膜。固定后,肿瘤切面呈灰白色,为实性肿瘤,有分叶。在我们的 15 例病例中未发现肿瘤钙化。肿瘤细胞呈实性片状生长,偶见角化,无滤泡或乳头结构。间质中的淋巴细胞浸润是该肿瘤的最特征性特征之一。肿瘤细胞为多边形上皮细胞,核仁明显,细胞边界不清晰。CD5 阳性免疫反应是将其与未分化癌、低分化癌、髓样(C 细胞)癌和甲状腺高级别鳞状细胞癌(所谓的原发性鳞状细胞癌)区分开来的关键特征。降钙素、TTF1 和甲状腺球蛋白阴性免疫反应,以及 p63 和 KIT 阳性免疫反应也有助于鉴别诊断。核异型性较轻,有丝分裂较少,增殖指数中等(MIB-1 标记指数通常小于 20%),这也有助于将其与甲状腺高级别原发性鳞状细胞癌区分开来。我们的 15 例肿瘤显示 3 种组织学亚型:角化鳞状细胞癌型、非角化基底样细胞癌(淋巴上皮样)型和神经内分泌癌型,与纵隔胸腺癌的亚型相对应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验